rs118203886
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP5
The ENST00000000000(TRNF):c.35G>A(p.Trp12*) variant causes a stop gained change involving the alteration of a conserved nucleotide. Variant has been reported in ClinVar as Pathogenic (no stars).
Frequency
Consequence
ENST00000000000 stop_gained
Scores
Clinical Significance
Conservation
Publications
- mitochondrial diseaseInheritance: Mitochondrial Classification: DEFINITIVE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: ENST00000387314.1. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
There are no transcript annotations for this variant. | |||||||||
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MT-TF | ENST00000387314.1 | TSL:6 | n.35G>A | non_coding_transcript_exon | Exon 1 of 1 | ||||
| MT-RNR1 | ENST00000389680.2 | TSL:6 | n.-37G>A | upstream_gene | N/A |
Frequencies
Mitomap
ClinVar
Submissions by phenotype
MERRF syndrome Pathogenic:1Other:1
Mitochondrial disease Uncertain:1
The m.611G>A variant in MT-TF has been reported in one individual with primary mitochondrial disease (PMID: 15184630). This individual had a clinical diagnosis of myoclonic epilepsy with ragged red fibers (MERRF) characterized by progressive myoclonus, migraines, exercise intolerance, imbalance, memory impairment, progressive sensorineural hearing loss, restricted upgaze, and short stature. Muscle biopsy showed ragged red and COX-deficient fibers. The variant was present at 91% in skeletal muscle and was undetectable in blood, buccal cells, and urinary sediment. The variant was not detected in blood, buccal cells, or urinary sediment from the mother, brother, and daughter. This variant is absent in the GenBank dataset, Helix dataset, and gnomAD v3.1.2 (PM2_supporting). MitoTIP predicts the variant is possibly pathogenic (51.2 percentile) and HmtVAR predicts the variant is pathogenic (score of 0.85, PP3). Single fiber testing showed higher levels of the variant in COX-negative ragged red fibers (93.3 ± 4%, n=10) than in COX-positive non-ragged red fibers (17.4 ± 7.3%, n=10, PMID: 15184630). Furthermore, additional functional studies showed a decrease in aminoacylation activity compared to wild type (PMID: 17878308; PS3_moderate). In summary, this variant meets criteria to be classified as uncertain significance for primary mitochondrial disease inherited in a mitochondrial manner. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Variant Curation Expert Panel on June 10, 2024. Mitochondrial DNA-specific ACMG/AMP criteria applied (PMID: 32906214): PM2_supporting, PP3, PS3_moderate.
Computational scores
Source: